ConductScience.org, home

Trial · NCT07891637

Effects of a Novel Perturbation Balance Training Program on Laboratory and Real-World Trip-Induced Losses of Balance and Falls Among Balance-Impaired Older Adults

NCT07891637, Not applicable, Not yet recruiting, Virginia Polytechnic Institute and State University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effects of a Novel Perturbation Balance Training Program on Laboratory and Real-World Trip-Induced Losses of Balance and Falls Among Balance-Impaired Older Adults. Trials, record NCT07891637. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891637

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effects of a Novel Perturbation Balance Training Program on Laboratory and Real-World Trip-Induced Losses of Balance and Falls Among Balance-Impaired Older Adults
NCT number
NCT07891637
Status
Not yet recruiting
Phases
Not applicable
Enrollment
180 participants, estimated
Lead sponsor
Virginia Polytechnic Institute and State University
Conditions
Accidental Fall
Interventions
Step Training, Treadmill Training, Otago Exercise Program
First posted
2026-10-23
Last updated
2026-10-23

Source ClinicalTrials.gov

Registered outcomes10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTrunk angle during balance recovery after lab-induced tripBefore intervention, 1-week after intervention, and 6-months after intervention.
Angle from vertical to a line connecting midpoint of greater trochanter markers and midpoint of acromion markers, measured at the instant of touchdown of the first step over the trip obstacle. This outcome measure will only be obtained from the n=60 subjects at Virginia Tech.
PrimaryRecovery step length after lab-induced tripBefore intervention, 1-week after intervention, and 6-months after intervention.
The distance between a lateral malleolus marker of the stance limb and a lateral malleolus marker of the stepping limb after the first step over the tripping obstacle. This outcome measure will only be obtained from the n=60 subjects at Virginia Tech.
PrimaryRecovery step speed after lab-induced tripBefore intervention, 1-week after intervention, and 6-months after intervention.
Step length divided by step time. Step length is the distance between a lateral malleolus marker of the stance limb and a lateral malleolus marker of the stepping limb after the first step over the tripping obstacle. Step time is the time from the foot first contacting the trip obstacle and the first step over the trip obstacle contacting the floor. This outcome measure will only be obtained from the n=60 subjects at Virginia Tech.
PrimaryFall rate after lab-induced tripBefore intervention, 1-week after intervention, 6-months after intervention.Number of falls into a safety harness divided by the total number of trips. This outcome measure will only be obtained from the n=60 subjects at Virginia Tech.
PrimaryNumber of real-world losses of balance during 12-month follow upFrom the end of intervention until 12 months later.This outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.
PrimaryNumber of real-world balance recoveries during 12-month follow upFrom the end of intervention until 12 months laterThis outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.
PrimaryNumber of real-world falls during 12-month follow upFrom the end of intervention until 12 months laterThis outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.
SecondaryShort Portable Performance BatteryBefore intervention, 1-week after intervention, and 6-months after intervention.
A standardized clinical mobility test involving gait speed, standing balance, and chair rises. This outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.
SecondaryBerg Balance ScaleBefore intervention, 1-week after intervention, and 6-months after intervention.
A standardized clinical mobility test involving multiple balance components and an overall composite score that can predict falls. This outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.
SecondaryActivities Balance Confidence ScaleBefore intervention, 1-week after intervention, and 6-months after intervention.
A standardized questionnaire that involves subjects rating their confidence to avoid falls while doing common activities. This outcome measure will be obtained from the n=180 subjects across both sites at Virginia Tech and University of Michigan.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
R01AG097954Effects of a novel perturbation balance training program on laboratory and real-world trip-induced losses of balance and falls among balance-impaired older adultsMADIGAN, MICHAEL L; Alexander, NeilVIRGINIA POLYTECHNIC INST AND ST UNIVNATIONAL INSTITUTE ON AGING2026

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07891637

GET https://conductscience.org/api/trials/v1/NCT07891637/registered